Estia Health Ltd (ASX: EHE) has delivered a pleasing result despite a challenging period for residential aged care providers in Australia.

Estia Health is one of Australia’s largest residential aged care providers. The company operates 69 facilities with more than 6,000 operational beds up and down the east coast of Australia and in South Australia.

Highlights From The Financial Results

Estia recorded a net profit after tax (NPAT) of $41.3 million which was in line with the 2018 financial year (FY18) result. Earnings before interest, tax, depreciation and amortisation was up 4.3% to $94 million on the back of a 7% increase in group revenue to $586 million.

The following Rask Finance video explains the difference between revenue and profit:

An important figure that Estia Health monitors closely is the average occupancy rate of its centres, which was 93.6% for during FY19. This was seen as a very solid outcome given occupancy rates across the industry had come under significant pressure in the past 12 months.

The higher the occupancy rate the better, as it means more beds are being utilised and generating revenue Estia Health. The company reported that the spot occupancy rate was at 94.1% on August 16.

Estia has continued to expand its operations to take advantage of the growth in demand for aged care facilities. During FY19 the company invested $93.8 million in expanding and enhancing the ‘home’ portfolio.

Estia Health is in a sound financial position with a net debt to equity ratio at 14%. As a result, management believes the company is well prepared for the new quality standards in the wake of the royal commission into aged care.

Estia Health’s board declared a final dividend of 7.8 cents per share which serves to maintain the full-year dividend of 15.8 cents per share. This places Estia shares on a healthy trailing dividend yield of 5.7%.

Management Comments

Estia CEO Ian Thorley admitted it had been a particularly difficult year for the business saying:

“There is no doubt that this has been one of the most challenging periods for the aged care sector. Continuing to lift quality of care and amenity for residents, while maintaining our financial results, reflects the hard work and dedication of our 7,500 team members, our resident-centred operating model and our disciplined approach to managing costs and capital.”

In relation to the Royal Commission into aged care, Mr Thorley remarked that Estia is, “well prepared for the introduction of the new quality standards, with additional investment in quality management and resident care systems including staff education, technology development, customer engagement and service.”

Buy, Hold or Sell?

I find the aged care sector, which includes Estia’s peers Japara Healthcare Ltd (ASX: JHC) and Aveo Group (ASX: AOG), extremely difficult to assess as it remains heavily reliant on favourable government regulation. Adding to the regulatory uncertainty is the reputational damage caused by the Royal Commission. Only time will tell if the worst is now behind us.


After searching through a market with over 2,000 shares, our lead expert investment analyst has narrowed it down to just 2 of his favourite small-cap pocket rocket share ideas in a FREE report to Rask Media readers.

Over the past five years, these two shares have gone from being 'tiny caps' to being serious contenders for the ASX 300.

Access the free report by clicking here now or enter your email below! Absolutely no credit card or payment details required.

Disclaimer: Any information contained in this article is limited to general financial/investment advice only. The information has not taken into account your specific needs, goals or objectives, so please consider consulting a licenced and trusted adviser before acting on the information. Please read The Rask Group’s Financial Services Guide (FSG) for more information. This article is authorised by Owen Raszkiewicz of The Rask Group, which is a corporate authorised representative No. 1264179 of Strawman Pty Ltd (ACN: 610 908 211) (AFSL: 501 223).

Disclosure: At the time of publishing, Luke has no financial interest in any companies mentioned.